December 26, 2014 7:42 AM ET

Pharmaceuticals

Company Overview of Teva Biopharmaceuticals USA, Inc.

Company Overview

Teva Biopharmaceuticals USA, Inc. engages in the discovery and development of biopharmaceuticals and long-acting medicines for various therapeutic areas. It offers HSA-fusion peptides and proteins for various diseases, including cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases. The company was formerly known as CoGenesys, Inc. and changed its name to Teva Biopharmaceuticals USA, Inc. in February 2008 following its acquisition by Teva Pharmaceutical Industries Limited. The company was founded in 2005 and is based in Rockville, Maryland. As of February 21, 2008, Teva Biopharmaceuticals USA, Inc. operates as a subsidiary of Teva Pharmaceutical Industries Ltd.

9410 Key West Avenue

Rockville, MD 20850-3345

United States

Founded in 2005

Phone:

240-821-9000

Fax:

240-821-9001

Key Executives for Teva Biopharmaceuticals USA, Inc.

Co-Founder
Age: 60
Co-Founder and Chief Technology Officer
Co-Founder and Chief Business Officer
Chief Financial Officer
Senior Vice President of Clinical Development and Regulatory Affairs
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
ARMGO Pharma, Inc. United States
Aidan Products, LLC United States
IPR Pharmaceuticals Inc. United States
R.P. Scherer Technologies, Inc. United States
Savara Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Teva Biopharmaceuticals USA, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.